Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.30 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triphosphate SCHEMBL595229 | 0.94 | P2RX3 (0.38) | ALDH1A1KDM4ERXFP1P2RX3FDPS | |
| Purine SCHEMBL27554272 | 0.90 | ALDH1A1 (0.39) | ALDH1A1KDM4ERXFP1FDPSNTRK1 | |
| Purine SCHEMBL5989434 | 0.90 | ALDH1A1 (0.39) | ALDH1A1KDM4ERXFP1FDPSNTRK1 | |
| Purine SCHEMBL595231 | 0.90 | ALDH1A1 (0.39) | ALDH1A1KDM4ERXFP1FDPSNTRK1 | |
| Purine SCHEMBL2676962 | 0.87 | ALDH1A1 (0.41) | ALDH1A1KDM4ERXFP1FDPSNTRK1 | |
| Triphosphate SCHEMBL7453135 | 0.86 | P2RX3 (0.35) | P2RX3 | |
| Triphosphate SCHEMBL9104232 | 0.84 | P2RX3 (0.36) | P2RX3 | |
| Purine SCHEMBL28271 | 0.83 | ALDH1A1 (0.39) | ALDH1A1KDM4ERXFP1PDPK1 | |
| Purine SCHEMBL28164598 | 0.82 | ALDH1A1 (0.44) | ALDH1A1KDM4ERXFP1PDPK1 | |
| Purine SCHEMBL2120554 | 0.82 | ALDH1A1 (0.47) | ALDH1A1KDM4ERXFP1PDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12529078-B2 | Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis | GENOMATICA, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-20240294950-A1 | MICROORGANISMS AND METHODS FOR IMPROVING PRODUCT YIELDS ON METHANOL USING ACETYL-COA SYNTHESIS | AGAIN BIO APS (DK) | 2024-09-05 | — | — | US | disclosed |
| EP-4421181-A2 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | Genomatica, Inc. (US) | 2024-08-28 | — | — | EP | disclosed |
| EP-4389904-A2 | MICROORGANISMS FOR PRODUCING 4C-5C COMPOUNDS WITH UNSATURATION AND METHODS RELATED THERETO | Genomatica, Inc. (US) | 2024-06-26 | — | — | EP | disclosed |
| US-11932893-B2 | Microorganisms and methods for producing alkenes | GENOMATICA, INC. (US) | 2024-03-19 | — | — | US | disclosed |
| EP-3741865-B1 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | GENOMATICA INC (US) | 2024-03-13 | — | — | EP | disclosed |
| EP-3164495-B1 | MICROORGANISMS FOR PRODUCING 4C-5C COMPOUNDS WITH UNSATURATION AND METHODS RELATED THERETO | GENOMATICA INC (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-4296364-A2 | MICROORGANISMS AND METHODS FOR IMPROVING PRODUCT YIELDS ON METHANOL USING ACETYL-COA SYNTHESIS | Genomatica, Inc. (US) | 2023-12-27 | — | — | EP | disclosed |
| EP-3967747-B1 | MICROORGANISMS AND METHODS FOR IMPROVING PRODUCT YIELDS ON METHANOL USING ACETYL-COA SYNTHESIS | GENOMATICA INC (US) | 2023-11-08 | — | — | EP | disclosed |
| US-20230348981-A1 | METHODS AND COMPOSITIONS FOR INHIBITING AND TREATING NEUROLOGICAL CONDITIONS | POPULATION BIO, INC. | 2023-11-02 | — | — | US | disclosed |
| EP-1451355-A1 | METHODS AND SYSTEMS FOR IDENTIFYING NATURALLY OCCURRING ANTISENSE TRANSCRIPTS AND METHODS, KITS AND ARRAYS UTILIZING SAME | Compugen Ltd. (IL) | 2004-09-01 | — | — | EP | disclosed |
| US-20040142325-A1 | Methods and systems for annotating biomolecular sequences | COMPUGEN LTD. (IL) | 2004-07-22 | — | — | US | disclosed |
| US-20040101876-A1 | Methods and systems for annotating biomolecular sequences | COMPUGEN LTD. (IL) | 2004-05-27 | — | — | US | disclosed |
| US-20040086954-A1 | Assay for kinases and phosphatases | GOUELI SAID (US) | 2004-05-06 | — | — | US | disclosed |
| US-6720162-B2 | PHOSPHORYLATION | PROMEGA CORPORATION | 2004-04-13 | — | — | US | disclosed |
| US-20030228618-A1 | Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same | COMPUGEN LTD. (IL) | 2003-12-11 | — | — | US | disclosed |
| WO-2003046220-A1 | METHODS AND SYSTEMS FOR IDENTIFYING NATURALLY OCCURRING ANTISENSE TRANSCRIPTS AND METHODS, KITS AND ARRAYS UTILIZING SAME | COMPUGEN LTD. (IL) | 2003-06-05 | — | — | WO | disclosed |
| EP-1290213-A2 | ASSAY FOR KINASES AND PHOSPHATASES | PROMEGA CORPORATION (US) | 2003-03-12 | — | — | EP | disclosed |
| US-20020028477-A1 | Assay for kinases and phosphatases | PROMEGA CORPORATION | 2002-03-07 | — | — | US | disclosed |
| WO-2001092560-A2 | ASSAY FOR KINASES AND PHOSPHATASES | PROMEGA CORPORATION (US) | 2001-12-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529078-B2 | Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis | ALDOA, FDPS, DERA | ALDH1A1 385/4885KDM4E 409/4885RXFP1 4507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.